We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Neural "Noise" May Signal Psychiatric Treatment Efficacy
News

Neural "Noise" May Signal Psychiatric Treatment Efficacy

Neural "Noise" May Signal Psychiatric Treatment Efficacy
News

Neural "Noise" May Signal Psychiatric Treatment Efficacy

Credit: cottonbro/ Pexels
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Neural "Noise" May Signal Psychiatric Treatment Efficacy"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

It remains a central challenge in psychiatry to reliably judge whether a patient will respond to treatment. In a new study published in the journal Biological Psychiatry, researchers from Karolinska Institutet in Sweden and the Max Planck Institute for Human Development in Germany show that moment-to-moment fluctuations in brain activity can reliably predict whether patients with social anxiety disorder will be receptive to cognitive behavioural therapy (CBT).

Viable predictors of psychiatric treatment response are often sought, but remain elusive. Brain imaging techniques such as functional magnetic resonance imaging (fMRI) have shown promise, but low reliability has limited the utility of typical fMRI measures as harbingers of treatment success. Although historically considered a marker of ‘noise’ in the brain, moment-to-moment brain signal variability continues to gain momentum as a sensitive and reliable indicator of individual differences in the effectiveness of neural function. However, neural variability had not yet been examined in relation to psychiatric treatment outcomes.

Strongest and most reliable predictor


To do so, the research team designed a unique study; 45 patients with social anxiety disorder had their brains imaged during passive rest and emotional face viewing (a social anxiety-relevant task) in two sessions (11 weeks apart) to capture moment-to-moment neural variability. Then, patients underwent a 9-week cognitive behavioural therapy delivered via the internet. The researchers showed that brain signal variability measured during the emotional task was the strongest and most reliable predictor of treatment outcome, despite the task only taking three minutes for patients to complete. 

“Variability in brain signals is often considered measurement ‘noise,’ something to be eliminated prior to further analysis. We show first evidence that neural variability may be a reliable and efficient predictor of psychiatric treatment outcome, particularly when disorder-relevant task designs are utilized. We simply need to rethink our standard approaches in psychiatric neuroimaging to maximize clinical impact,” says lead author Dr. Kristoffer Månsson, clinical psychologist and researcher at the Department of Clinical Neuroscience, Karolinska Institutet.

In the next phase of their research, the authors will collect larger samples to examine whether brain signal variability can predict which specific treatment a patient should undergo.

Tailored treatment


“If moment-to-moment neural variability is to be worth its salt as a clinically useful predictor of treatment outcome, it needs to tell clinicians not only how much a patient will respond to a given treatment, but whether treatment A or B is better suited for them. Establishing this will be our long-term goal. In the meantime, our methods are immediately and openly available to any researcher interested in whether neural variability provides clinical utility within and beyond social anxiety disorder patients,” says senior author Dr. Douglas Garrett, leader of the Lifespan Neural Dynamics Group at the Max Planck UCL Centre for Computational Psychiatry and Ageing Research in Berlin.

Reference: Månsson KNT, Waschke L, Manzouri A, Furmark T, Fischer H, Garrett DD. Moment-to-moment brain signal variability reliably predicts psychiatric treatment outcome. Biol. Psychiatry. 2021;0(0). doi: 10.1016/j.biopsych.2021.09.026

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.


Advertisement